scispace - formally typeset
T

Takeo Yoshikawa

Researcher at RIKEN Brain Science Institute

Publications -  294
Citations -  13261

Takeo Yoshikawa is an academic researcher from RIKEN Brain Science Institute. The author has contributed to research in topics: Single-nucleotide polymorphism & Bipolar disorder. The author has an hindex of 57, co-authored 263 publications receiving 12000 citations. Previous affiliations of Takeo Yoshikawa include Tokyo Medical and Dental University & Tokyo Metropolitan Matsuzawa Hospital.

Papers
More filters
Journal ArticleDOI

Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder.

Ricardo Segurado, +79 more
TL;DR: The present results for the very narrow model are promising but suggest that more and larger data sets are needed to support linkage, as well as suggest that linkage might be detected in certain populations or subsets of pedigrees.
Journal ArticleDOI

O1-7-4-1Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease

TL;DR: Clinical and genetic information of 5 Japanese patients with Bardet-Biedl syndrome is summarized and it is found that rare liver fibrosis was detected in two patients, while only two patients had renal dysfunction, thought to be a universal symptom.
Journal ArticleDOI

A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2

TL;DR: By comprehensive screening of the entire genome, a genome-wide scan is conducted on approximately 396 individuals from 22 multiplex pedigrees by using 607 microsatellite markers to detect unreported loci for bipolar disorder, found support for proposed linkages, and gained evidence for the overlap of susceptibility regions for bipolar Disorder and schizophrenia.
Journal ArticleDOI

Increased L1 Retrotransposition in the Neuronal Genome in Schizophrenia

TL;DR: High L1 copy number in schizophrenia was demonstrated in neurons from prefrontal cortex of patients and in induced pluripotent stem (iPS) cell-derived neurons containing 22q11 deletions, suggesting hyperactive retrotransposition of L1 in neurons triggered by environmental and/or genetic risk factors may contribute to the susceptibility and pathophysiology of schizophrenia.